http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015007025-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9df90d7822cc480ce12c480f4089e229 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4babe3a8fc3f278a89759d55735f639e |
| publicationDate | 2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015007025-A |
| titleOfInvention | Human Fas ligand extracellular domain site-specific chemical modification |
| abstract | Provided is a human Fas ligand extracellular domain protein subjected to site-specific chemical modification that retains a receptor binding function in order to introduce a desired property without impairing the original biological activity. A cysteine residue connected to the amino terminal site of the human Fas ligand extracellular domain, separated from the interfacial site of the ligand-receptor specific interaction between the human Fas ligand extracellular domain and the human Fas receptor protein. Human Fas ligand extracellular domain site-specific chemical modification having chemical modification with a compound containing a reactive site that specifically binds to a cysteine residue. |
| priorityDate | 2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.